Groene Oliver, Sunol Rosa, Klazinga Niek S, Wang Aolin, Dersarkissian Maral, Thompson Caroline A, Thompson Andrew, Arah Onyebuchi A
Faculty of Public Health and Policy, London School of Hygiene & Tropical Medicine, 15-17 Tavistock Place, London WC1H 9SH, UK.
Int J Qual Health Care. 2014 Apr;26 Suppl 1(Suppl 1):81-91. doi: 10.1093/intqhc/mzu022. Epub 2014 Mar 9.
The objective of this study was to describe the involvement of patients or their representatives in quality management (QM) functions and to assess associations between levels of involvement and the implementation of patient-centred care strategies.
A cross-sectional, multilevel
that surveyed quality managers and department heads and data from an organizational audit.
Randomly selected hospitals (n = 74) from seven European countries (The Czech Republic, France, Germany, Poland, Portugal, Spain and Turkey).
Hospital quality managers (n = 74) and heads of clinical departments (n = 262) in charge of four patient pathways (acute myocardial infarction, stroke, hip fracture and deliveries) participated in the data collection between May 2011 and February 2012.
Four items reflecting essential patient-centred care strategies based on an on-site hospital visit: (1) formal survey seeking views of patients and carers, (2) written policies on patients' rights, (3) patient information literature including guidelines and (4) fact sheets for post-discharge care. The main predictors were patient involvement in QM at the (i) hospital level and (ii) pathway level.
Current levels of involving patients and their representatives in QM functions in European hospitals are low at hospital level (mean score 1.6 on a scale of 0 to 5, SD 0.7), but even lower at departmental level (mean 0.6, SD 0.7). We did not detect associations between levels of involving patients and their representatives in QM functions and the implementation of patient-centred care strategies; however, the smallest hospitals were more likely to have implemented patient-centred care strategies.
There is insufficient evidence that involving patients and their representatives in QM leads to establishing or implementing strategies and procedures that facilitate patient-centred care; however, lack of evidence should not be interpreted as evidence of no effect.
本研究的目的是描述患者或其代表参与质量管理(QM)职能的情况,并评估参与程度与以患者为中心的护理策略实施之间的关联。
一项横断面、多层次的
对质量管理人员和部门负责人进行调查,并收集来自组织审计的数据。
从七个欧洲国家(捷克共和国、法国、德国、波兰、葡萄牙、西班牙和土耳其)随机选取的医院(n = 74)。
负责四条患者就医路径(急性心肌梗死、中风、髋部骨折和分娩)的医院质量管理人员(n = 74)和临床科室负责人(n = 262)于2011年5月至2012年2月参与了数据收集。
基于医院实地考察,反映以患者为中心的基本护理策略的四个项目:(1)征求患者和护理人员意见的正式调查,(2)关于患者权利的书面政策,(3)包括指南在内的患者信息文献,以及(4)出院后护理情况说明书。主要预测因素是患者在(i)医院层面和(ii)就医路径层面参与质量管理的情况。
欧洲医院中患者及其代表目前参与质量管理职能的程度在医院层面较低(0至5分制下平均得分为1.6,标准差为0.7),但在科室层面更低(平均0.6,标准差0.7)。我们未发现患者及其代表参与质量管理职能的程度与以患者为中心的护理策略实施之间存在关联;然而,规模最小的医院更有可能实施了以患者为中心的护理策略。
没有充分证据表明让患者及其代表参与质量管理会导致建立或实施促进以患者为中心护理的策略和程序;然而,缺乏证据不应被解释为没有效果的证据。